Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
Status:
Recruiting
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
This is a study of oral nisin administration in patients with OSCC who are undergoing
complete surgical resection surgery with or without adjuvant radiation/chemoradiation as part
of their routine care at the University of California, San Francisco (UCSF).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
National Cancer Institute (NCI) University of California, Los Angeles